| 23/01 | Avis d'analystes du jour : Sartorius Stedim Biotech, Unibail, R.. |  |
| 19/01 | Galapagos : J.P. Morgan Healthcare Conference January 9, 2023 - Form 6-K |  |
| 10/01 | Galapagos receives transparency notification from FMR LLC | |
| 10/01 | Galapagos receives transparency notification from FMR LLC | |
| 03/01 | Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference | |
| 03/01 | Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Bolsa de Madrid: Todavía en modo ciclotímico |  |
| 2022 | Toujours en mode cyclothymique | |
| 2022 | En Direct des Marchés : Stellantis, GTT, Valneva, BHP, Tesla, Meta.. | |
| 2022 | Belgian Biotech Galapagos' Chief Medical Officer, Chief Business Officer To Step Down a.. | |
| 2022 | Galapagos announces changes to Executive Committee | |
| 2022 | Galapagos announces changes to Executive Committee | |
| 2022 | Galapagos NV Announces Changes in the Executive Committee Effective 1 January 2023 | |
| 2022 | GALAPAGOS : la biotech belge cherche un rival à acheter | |
| 2022 | Belgian Biotech Galapagos Eyes Purchase of Early-stage Drugmakers in Europe, CEO Says | |
| 2022 | Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a .. | |
| 2022 | Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a .. | |
| 2022 | Galapagos and CellPoint Presented Encouraging Initial Data AtASH 2022 for GLPG5101, a C.. | |
| 2022 | European Medicines Agency Panel Adopts Recommendation for Galapagos' Jyseleca Product L.. | |
| 2022 | Galapagos announces CHMP adoption of PRAC's recommendation for Jyseleca® following exte.. | |
| 2022 | Galapagos announces CHMP adoption of PRAC's recommendation for Jyseleca® following exte.. | |
| 2022 | Galapagos Announces CHMP Adoption of PRAC’s Recommendation for Jyseleca® Following.. | |
| 2022 | Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study.. | |
| 2022 | Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study.. | |
| 2022 | Galapagos NV to present encouraging initial data from FILOSOPHY real-world arthritis st.. | |
| 2022 | Galapagos NV Revises Revenue Guidance of Jyseleca for the Full Year 2022 | |
| 2022 | Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022 | |
| 2022 | Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022 | |
| 2022 | Galapagos announces strategy to accelerate innovation and reports strong third quarter .. | |
| 2022 | Galapagos NV Reports Earnings Results for the Nine Months Ended September 30, 2022 | |
| 2022 | Galapagos : Press release dated October 17, 2022 - Form 6-K | |
| 2022 | Galapagos to host its R&D Update 2022 in New York on 4 November 2022 | |
| 2022 | Galapagos to host its R&D Update 2022 in New York on 4 November 2022 | |
| 2022 | Galapagos to Present Data on Prospective Ulcerative Colitis Treatment at Upcoming Confe.. | |
| 2022 | Galapagos provides further insights into the treatment of ulcerative colitis at the upc.. | |
| 2022 | Galapagos provides further insights into the treatment of ulcerative colitis at the upc.. | |
| 2022 | Galapagos Says It Secured Positive Regulatory Opinion on Jyseleca's European Label Upda.. | |
| 2022 | Galapagos Wins EU Health Agency Backing To Remove Male Fertility Warning On Jyseleca's .. | |
| 2022 | Galapagos NV Says It Secures Positive Regulatory Opinion on Jyseleca's European Label U.. | |
| 2022 | Galapagos receives positive CHMP opinion for Jyseleca® European label update based on t.. | |
| 2022 | Galapagos receives positive CHMP opinion for Jyseleca® European label update based on t.. | |
| 2022 | Galapagos Receives Positive CHMP Opinion for Jyseleca® European Label Update Based on T.. | |
| 2022 | Galapagos increases share capital through subscription right exercises | |
| 2022 | Galapagos increases share capital through subscription right exercises | |
| 2022 | Galapagos NV announced that it has received €3.07625 million in funding | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos to present at upcoming investor conferences | |
| 2022 | Galapagos to present at upcoming investor conferences | |
| 2022 | Galapagos : receives transparency notification from FMR LLC - Form 6-K | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos : receives transparency notification from FMR LLC - Form 6-K | |
| 2022 | Galapagos : First key steps in pipeline rebuild and strong commercial progress in H1 2022 .. | |
| 2022 | Galapagos NV Revises Revenue Guidance of Jyseleca for the Full Year 2022 | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos Q2 Loss Narrows as Net Revenue Falls | |
| 2022 | First key steps in pipeline rebuild and strong commercial progress in H1 2022 | |
| 2022 | Galapagos NV Reports Earnings Results for the Half Year Ended June 30, 2022 | |
| 2022 | Actualización de las fuertes variaciones del día: L.. | |
| 2022 | Point sur les fortes variations du jour : début de .. | |
| 2022 | Bolsa de Madrid: Embotellamientos de verano | |
| 2022 | Embouteillages estivaux | |
| 2022 | Avis d'analystes du jour : BNP Paribas, Adecco, Ubisoft, UCB, C.. | |
| 2022 | Galapagos : to acquire CellPoint and AboundBio to accelerate access to next-generation cel.. | |
| 2022 | Galapagos : increases share capital through subscription right exercises - Form 6-K | |
| 2022 | Pharmaceutical Group Galapagos Buys Cell Therapy Developers CellPoint, AboundBio For $2.. | |
| 2022 | Galapagos Expands Cell Therapy Capabilities Through Two Acquisitions | |
| 2022 | Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation ce.. | |
| 2022 | Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation ce.. | |
| 2022 | Galapagos NV acquired CellPoint B.V. from ND Capital and others for approximately €.. | |
| 2022 | Galapagos NV acquired Abound Bio, Inc. for $14 million. | |
| 2022 | Galapagos increases share capital through subscription right exercises | |
| 2022 | Galapagos increases share capital through subscription right exercises | |
| 2022 | Galapagos NV announced that it expects to receive €1.459507 million in funding | |
| 2022 | Galapagos : receives transparency notification from FMR LLC - Form 6-K | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos receives transparency notification from FMR LLC | |
| 2022 | Galapagos : to showcase commitment to rheumatoid arthritis care at the upcoming European L.. | |
| 2022 | Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European .. | |
| 2022 | Galapagos In-Licenses Drug Targets for Inflammatory Bowel Disease From Scipher | |
| 2022 | Intervest Offices & Warehouses Extends Lease Deals For Office Portfolio In Belgium | |
| 2022 | Galapagos creates new subscription right plans | |
| 2022 | Galapagos creates new subscription right plans | |
| 2022 | Galapagos demonstrates regulatory and commercial progress in Q1 2022 | |
| 2022 | Galapagos NV Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 2022 | Galapagos NV Declares Voting Results | |
| 2022 | Galapagos : announces appointment of Dr. Paul Stoffels as Chairman of the board - Form 6-K | |
| 2022 | Galapagos Names CEO As Chairman Under New Governance Structure | |
| 2022 | Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board | |
| 2022 | Galapagos NV Announces Executive Appointments | |
| 2022 | E-therapeutics Achieves Key Milestones Under Collaboration with Galapagos | |
| 2022 | E-therapeutics plc Announces A Key Milestone in Its Collaboration with Galapagos | |
| 2022 | Subject : Galapagos AGM/EGM 2022 April 11th, 2022 - Form 6-K | |
| 2022 | Galapagos : Chairman letter to shareholders | |
| 2022 | Galapagos : Glpg egm & agm 2022 | |
| 2022 | Galapagos NV Announces Approval of Additional Indication Based on Phase 2B/3 SELECTION .. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
